The Houston Chronicle, March 19, 2020

UTMB will be testing a new drug developed by a Houston biotech company that may be useful for those infected with coronaviruses. Initially evaluated for cancer, the company now believes it could prove useful against viruses. “This is something that we’re going to be trying on the coronavirus that causes COVID-19 as soon as possible,” said UTMB’s Mark Emmett. [See the attached file for the full text of the story.]